PF-Atlas › Clinical Trials › NCT00625703

Pharmacokinetics of Linezolid in Children With Cystic Fibrosis

Linezolid · Phase 2

Registry ID

NCT00625703

Phase

Phase 2

Status

Completed

Drug / intervention

Linezolid

Sponsor

University of Texas Southwestern Medical Center

Start

2010-12

Enrollment

Locations

About this trial

To determine the pharmacokinetic profile of IV (intravenous) and PO (oral) formulations of linezolid among children with cystic fibrosis and establish a dose regimen that will be safe and effective.

View NCT00625703 on ClinicalTrials.gov →

Explore related

All Linezolid trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00625703 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.